BioCentury
ARTICLE | Tools & Techniques

BAFFling autoimmune disease

June 23, 2003 7:00 AM UTC

BAFFling autoimmune disease

In deciding to partner development of its BR3 protein, Biogen Inc. is extending its strategy of using partnerships to accelerate internal projects. While BGEN's cancer deal earlier this year with Idec Pharmaceuticals Corp. was outside of the company's core focus, last week's deal with Genentech Inc. for BR3 is in one of BGEN's focus areas, autoimmune disease...